Managing Recurrent Metastatic Head and Neck Cancer

Area of Science:

• Oncology
• Cancer Research
• Head and Neck Cancer Treatment

Background:

• Recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) presents limited therapeutic options with high morbidity.
• Effective local disease control remains a critical challenge in managing R/M HNSCC.

Purpose of the Study:

• To review the evolving treatment landscape for R/M HNSCC.
• To highlight the impact of recent advancements, particularly immunotherapy, on treatment strategies.

Main Methods:

• Literature review of recent clinical trials and treatment guidelines for R/M HNSCC.
• Analysis of the efficacy of local therapies, chemotherapy, targeted agents, and immunotherapy.

Main Results:

• Local therapies like reirradiation and salvage surgery can be considered for selected R/M HNSCC patients.
• Chemotherapy and targeted agents show modest efficacy in HNSCC.
• Immunotherapy has emerged as a revolutionary treatment modality for R/M HNSCC, with multiple trials supporting its use.

Conclusions:

• Immunotherapy, alone or combined with chemotherapy, has transformed the treatment paradigm for R/M HNSCC.
• Selected patients may benefit from a multimodal approach including local therapies and systemic treatment.